Tag: migraine
Theranica announces new study indicating meaningful impact of Nerivio from as...
Theranica has announced the results of a study, recently published in the journal Pain Management, suggesting the rapid impact of Nerivio—the first and only...
Nerivio neuromodulation therapy found to safely treat migraine in pregnant women
Theranica has announced the results of a study recently published in the journal Headache demonstrating the safety of its Nerivio device—a novel remote electrical...
Nerivio demonstrates real-world effectiveness as migraine treatment in adolescents
Theranica recently had the results from a real-world analysis of Nerivio for acute treatment of migraine in adolescents published in the journal Pediatric Neurology....
ObvioHealth to conduct decentralised trial with Mi-Helper device for treatment of...
ObvioHealth and Mi-Helper have announced a partnership to conduct a decentralised clinical trial with a small, non-invasive neuromodulation device for the treatment of migraines. The...
Drug-free migraine treatment gains additional US FDA clearance for preventative use
Theranica has announced that its drug-free Nerivio prescription wearable recently received US Food and Drug Administration (FDA) clearance as a dual-use acute and preventive...
RSNA 2022: New research improves understanding of ADHD, migraine and post-COVID...
The ongoing annual meeting of the Radiological Society of North America (RSNA; 27 November–1 December 2022, Chicago, USA) has seen a plethora of new...
Nerivio neuromodulation device achieves positive results in placebo-controlled migraine trial
Theranica Bio-electronics has announced positive top-line results in its double-blind, randomised, placebo-controlled, multicentre, pivotal clinical trial in the USA. This trial evaluated the efficacy...
Nerivio demonstrates comparable effectiveness to standard-care medications in chronic migraine
Theranica has announced the publication of a new study comparing the effectiveness of Remote electrical neuromodulation (REN) to that of standard-care medications for the acute treatment...
Theranica secures US$45 million through Series C funding round
Theranica has announced the closing of its Series C funding round, with a first closing of US$45 million. New Rhein Healthcare Investors led the...
Cefaly publishes study data indicating effectiveness of e-TNS migraine treatment
Cefaly Technology has announced the results of a clinical study demonstrating that two-hour treatment with its external trigeminal nerve stimulation (e-TNS) Cefaly device is...
Study shows positive impact of new in-app feature on Nerivio REN...
A new peer-reviewed study published in Pain Medicine, examining the use of Nerivio’s (Theranica) guided imagery, education and relaxation (GIER) in-app optional behavioural intervention...
Large real-world analysis deems Nerivio safe and effective in migraine treatment
Theranica has announced a new peer-reviewed study analysing the efficacy, safety and sustainability of remote electrical neuromodulation (REN) as a standalone, and medication-adjunct, treatment...
Study indicates safety and efficacy of remote electrical neuromodulation in chronic...
Theranica has announced the publication of a new, peer-reviewed article in Pain Reports detailing a study assessing its novel, drug-free treatment option for chronic...
Chordate Medical receives CE mark to treat chronic migraine with neuromodulation...
Chordate Medical has received a CE marking that permits its Kinetic Oscillation Stimulation (KOS) technology to be marketed, sold and used for the treatment...
ShiraTronics receives FDA breakthrough device designation for chronic migraine therapy
ShiraTronics has announced that it has been granted a breakthrough device designation by the Center of Devices and Radiological Health (CDRH) of the US...
Cervical non-invasive vagus nerve stimulation effectively relieves pain in migraine sufferers
A recent meta-analysis demonstrated that cervical non-invasive vagus nerve stimulation (nVNS) is a safe and effective method for acute pain relief in migraine and...
Physicians’ Education Resource releases agenda for the 1st Annual International Congress...
Physicians’ Education Resource (PER), a worldwide leading resource for continuing medical education (CME), announces the full agenda for the 1st Annual International Congress on...
The first non-invasive, adaptive neuromodulation digital treatment for migraine receives CE...
Neurolief, a developer of digital therapeutics brain neuromodulation technology, has announced that it has received the CE mark for its Relivion non-invasive, adaptive digital treatment...
Positive results published on the acute treatment of migraine using the...
Cephalalgia, the official peer-reviewed medical journal of the International Headache Society, has published positive results of the American multicentric clinical trial ACME (Acute migraine...
Migraines that affect vision may increase risk of irregular heartbeat
People who experience migraine with visual aura may have an increased risk of atrial fibrillation, according to a study published in the online issue...
Cefaly shown to successfully treat both chronic and refractory migraine
Two newly published clinical trial have demonstrated that Cefaly—the first US Food and Drug Administration-approved external trigeminal nerve stimulation device for the prevention of...
Wireless stimulation may ease migraine pain as well as drugs
A preliminary study suggests that a new, wireless patch that you wear on your arm may help reduce migraine pain as well as drugs....
Scientists discover non-invasive technique to monitor migraines
New University of British Columbia (Vancouver, Canada) research has found that amplified electroencephalograms can produce diagnostic results of cortical spreading depression that are comparable...
Cefaly releases revamped pocket-sized model of migraine headband
Cefaly has announced that its eponymous Cefaly device—which is a US Food and Drug Administration (FDA)-approved external trigeminal nerve stimulation device for the prevention...
